Day: September 5, 2023

Bolt Biotherapeutics to Participate in September Investor Conferences

REDWOOD CITY, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in September: Morgan Stanley 21st Annual Global Healthcare Conference Fireside chat on Tuesday, Sept. 12, at 3:35 p.m. EDT (12:35 p.m. PDT) H.C. Wainwright 25th Annual Global Investment Conference Management will be available for one-on-one meetings with investors on Wednesday, Sept. 13 A live webcast of the Morgan Stanley fireside chat will be available on the Events and Presentations page of Bolt’s website at www.boltbio.com. Archived replays will be available for 30 days following the event. About Bolt Biotherapeutics, Inc. Bolt Biotherapeutics is a clinical-stage...

Continue reading

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement

• Proceeds to support continued development and commercialization of Endocrine Rare Disease products and general corporate purposes NEW YORK and COPENHAGEN, Denmark, Sept. 05, 2023 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) and Ascendis Pharma A/S (Nasdaq: ASND) today announced that Royalty Pharma has entered into a $150 million capped synthetic royalty funding agreement with Ascendis based on U.S. net Skytrofa revenue. “This transaction reflects the significant value of Skytrofa. We are pleased to partner with Royalty Pharma, a leading funder of innovation across the biopharma industry, and look forward to partnering with them in the coming years,” said Jan Mikkelsen, Ascendis Pharma’s President and Chief Executive Officer. “With this funding, we continue to reduce our cost of capital and provide added flexibility to...

Continue reading

Parker Elects Denise Russell Fleming to its Board of Directors

CLEVELAND, Sept. 05, 2023 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced the election of Denise Russell Fleming to its Board of Directors, effective September 1, 2023. Ms. Fleming is currently Executive Vice President, Technology and Global Services and Chief Information Officer for BD (Becton, Dickinson & Company), one of the world’s leading medical technology companies. She was previously Vice President of Information Technology and Chief Information Officer for Boeing Defense, Space and Security (a division of The Boeing Company), and has more than 25 years of global experience in information technology, cyber risk management, general management, marketing and engineering.  “Denise is a seasoned executive whose unique combination of operational,...

Continue reading

Microchip Technology to Present at the Citi 2023 Global Technology Conference

CHANDLER, Ariz., Sept. 05, 2023 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Citi 2023 Global Technology Conference on Thursday, September 7 at 8:15 a.m. (Eastern Time). Presenting for the Company will be Mr. Ganesh Moorthy, President and Chief Executive Officer, and Mr. Nawaz Sharif, Vice President, Europe Finance and IR. A live webcast of the presentation will be made available by Citi, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can be...

Continue reading

Microchip Technology to Present at the Goldman Sachs 2023 Communacopia + Technology Conference

CHANDLER, Ariz., Sept. 05, 2023 (GLOBE NEWSWIRE) — Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Goldman Sachs 2023 Communacopia + Technology Conference on Wednesday, September 6 at 1:05 p.m. (Pacific Time). Presenting for the Company will be Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer, and Mr. Sajid Daudi, Head of Investor Relations. A live webcast of the presentation will be made available by Goldman, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings...

Continue reading

GENFIT to Participate in Upcoming Investor Conferences

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 05, 2023 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced that it will participate in the following upcoming investor conferences. Morgan Stanley 21st Annual Global Healthcare Conference Date: September 11-13, 2023Location: New York H.C. Wainwright 25th Annual Global Investment Conference Date: September 11-13, 2023Date of company presentation: September 12, 2023 at 9:30am ETLocation: New York Portzamparc BNP Paribas Biotech & Health SeminarDate: October 4-5, 2023Format: Digital Investor Access EventDate: October 9-10, 2023Location: Paris HealthTech Innovation DaysDate: October 24-25, 2023Location: Paris ABOUT GENFIT GENFIT...

Continue reading

XPO Provides North American LTL Operating Data for August 2023

GREENWICH, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for August 2023. LTL tonnage per day increased 3.1%, as compared with August 2022, attributable to a year-over-year increase of 8.1% in shipments per day and a decrease of 4.6% in weight per shipment. Actual results for August 2023 may vary from the preliminary results reported above. About XPO XPO, Inc. (NYSE: XPO) is one of the largest providers of asset-based less-than-truckload (LTL) transportation in North America, with proprietary technology that moves goods efficiently through its network. Together with its business in Europe, XPO serves approximately 49,000 customers with 562 locations and 37,000 employees. The company is headquartered...

Continue reading

Hub Group, Inc. to Participate in TD Cowen’s Global Transportation Conference

OAK BROOK, Ill., Sept. 05, 2023 (GLOBE NEWSWIRE) — Hub Group, Inc. (NASDAQ:HUBG) announced that the company will participate in a fireside chat at TD Cowen’s Global Transportation Conference on Thursday, September 7, 2023, at 1:20 p.m. Eastern time. A live webcast of the fireside chat discussion will be available at https://wsw.com/webcast/cowen140/hubg/1997158. A replay of the webcast will be available for 90 days following the live event. ABOUT HUB GROUP: Hub Group offers comprehensive transportation and logistics management solutions. Keeping our customers’ needs in focus, Hub Group designs, continually optimizes, and applies industry-leading technology to our customers’ supply chains for better service, greater efficiency, and total visibility. As an award-winning, publicly traded company (Nasdaq: HUBG) with over $5 billion...

Continue reading

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods

SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that certain CD Horizon® Solera® 5.5mm and 6.0mm posterior spinal fixation rods manufactured by Medtronic Sofamor Danek USA Inc., a division of Medtronic plc, meet SI-BONE’s criteria for compatibility with iFuse Bedrock Granite® indicated in the Granite implant’s instructions for use. A complete list of Medtronic Solera® rods meeting the criteria for compatibility described in Granite’s cleared labeling is available on SI-BONE’s website at: http://www.si-bone.com/granite-implant-solera-compatbibility-criteria. “Given the strong initial reception for Granite, we are thrilled to confirm that a number of Medtronic’s Solera® rods, used by many spine...

Continue reading

Stitch Fix Announces Date for Fourth Quarter and Full Fiscal Year 2023 Earnings Release and Conference Call

SAN FRANCISCO, Sept. 05, 2023 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the trusted online personal styling service, today announced that it will release financial results for its fourth quarter and full fiscal year 2023 ended July 29, 2023 after market close on Monday, September 18, 2023 followed by a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss Stitch Fix’s financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of the call will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. To access the call by phone, please register at this registration link. Upon registration, telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.